Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Vaccine

• Publication date

  2001-02-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(00)00434-5PMID 11228363
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of the immune response to papain digestion products of tetanus toxin.

  2009cited by this paper
• In Vivo Characterization of the Murine Intranasal Model for Assessing the Immunogenicity of Attenuated Salmonella enterica Serovar Typhi Strains as Live Mucosal Vaccines and as Live Vectors

  2000cited by this paper
• Human Dendritic Cells Are Superior to B Cells at Presenting a Major Histocompatibility Complex Class II-Restricted Heterologous Antigen Expressed on Recombinant Streptococcus gordonii

  2000cited by this paper
• The Structures of the HC Fragment of Tetanus Toxin with Carbohydrate Subunit Complexes Provide Insight into Ganglioside Binding*

  2000cited by this paper
• Immunogenicity of the B Monomer ofEscherichia coli Heat-Labile Toxin Expressed on the Surface of Streptococcus gordonii

  2000cited by this paper
• Expression of measles virus antigens in Streptococcus gordonii.

  2000cited by this paper
• Cell Surface-Exposed Tetanus Toxin Fragment C Produced by Recombinant Bacillus anthracis Protects against Tetanus Toxin

  1999cited by this paper
• Engineering the gram-positive cell surface for construction of bacterial vaccine vectors.

  1999cited by this paper
• Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis.

  1999cited by this paper
• Prior Immunity to Homologous and HeterologousSalmonella Serotypes Suppresses Local and Systemic Anti-Fragment C Antibody Responses and Protection from Tetanus Toxin in Mice Immunized with Salmonella Strains Expressing Fragment C

  1999cited by this paper
• Antigenicity and Immunogenicity of the V3 Domain of HIV Type 1 Glycoprotein 120 Expressed on the Surface of Streptococcus gordonii

  1999cited by this paper
• Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes.

  1999cited by this paper
• Functional characterisation of tetanus and botulinum neurotoxins binding domains.

  1999cited by this paper
• Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens.

  1998cited by this paper
• Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells.

  1998cited by this paper
• A Recombinant Live Attenuated Strain of Vibrio cholerae Induces Immunity against Tetanus Toxin andBordetella pertussis Tracheal Colonization Factor

  1998cited by this paper
• Vaginal Immunization with Recombinant Gram‐Positive Bacteria

  1998cited by this paper
• Recombinant Gram-positive bacteria as vehicles of vaccine antigens

  1997cited by this paper
• Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice.

  1997cited by this paper
• Gram-Positive Bacteria

  1997cited by this paper
• Oral vaccination of mice against tetanus with recombinant Lactococcus lactis

  1997cited by this paper
• Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxin.

  1997cited by this paper
• A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.

  1997cited by this paper
• Recombinant Streptococcus gordonii as a Live Vehicle for Vaccine Antigens

  1997cited by this paper
• A host-vector system for heterologous gene expression in Streptococcus gordonii.

  1996cited by this paper
• Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization.

  1995cited by this paper
• Immunization of mice by oral colonization with live recombinant commensal streptococci.

  1995cited by this paper
• The mechanism of action of tetanus and botulinum neurotoxins.

  1995cited by this paper
• Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii.

  1994cited by this paper
• Mechanism of action of tetanus and botulinum neurotoxins

  1994cited by this paper
• Characterization of the receptor-binding domain of tetanus toxin.

  1993cited by this paper
• Delivery and expression of a heterologous antigen on the surface of streptococci

  1992cited by this paper
• Use of the nirB Promoter to Direct the Stable Expression of Heterologous Antigens in Salmonella Oral Vaccine Strains: Development of a Single–Dose Oral Tetanus Vaccine

  1992cited by this paper
• Expression of M6 protein gene of Streptococcus pyogenes in Streptococcus gordonii after chromosomal integration and transcriptional fusion.

  1992cited by this paper
• Synthesis of tetanus toxin fragment C in insect cells by use of a baculovirus expression system

  1991cited by this paper
• Method and parameters for genetic transformation of Streptococcus sanguis Challis.

  1990cited by this paper
• Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells

  1988cited by this paper
• Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli

  1987cited by this paper
• Structure of tetanus toxin. N-Terminal amino acid analysis of the two molecular forms of tetanus toxin and its composite chains.

  1979cited by this paper
• Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments.

  1977cited by this paper

• Discovery and engineering of the antibody response to a prominent skin commensal

  2024cites this paper
• Immunotherapy for ovarian cancer is improved by tumor-targeted delivery of a neoantigen surrogate

  2023cites this paper
• Tumor-targeted delivery of Tetanus toxoid by Listeria improves immunotherapy against ovarian cancer in mice

  2023cites this paper
• Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production

  2022cites this paper
• Decorated bacteria and the application in drug delivery.

  2022cites this paper
• Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice

  2022influential citation
• Alternative vaccine delivery methods

  2020cites this paper
• Identification of the anchoring protein SpoIIIJ for construction of the microbial cell surface display system in Bacillus spp.

  2019cites this paper
• Tumor-targeted delivery of childhood vaccine recall antigens by attenuated Listeria reduces pancreatic cancer

  2019cites this paper
• RETRACTED CHAPTER: Changing Paradigm of Probiotics from Functional Foods to Biotherapeutic Agents

  2018cites this paper
• University of Groningen Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization Audouy,

  2018cites this paper
• Recent progress in Bacillus subtilis spore-surface display: concept, progress, and future

  2017cites this paper
• Identification of the chain-dispersing peptidoglycan hydrolase LytB of Streptococcus gordonii

  2017cites this paper
• Fundamentos y casos exitosos de la biotecnología moderna

  2016cites this paper
• Tetanus vaccination with a dissolving microneedle patch confers protective immune responses in pregnancy.

  2016cites this paper
• Evaluation of the effect of MPL and delivery route on immunogenicity and protectivity of different formulations of FimH and MrpH from uropathogenic Escherichia coli and Proteus mirabilis in a UTI mouse model.

  2015cites this paper
• Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes

  2015cites this paper
• Development of a Streptococcus gordonii vaccine strain expressing Schistosoma japonicum Sj-F1 and evaluation of using this strain for intranasal immunization in mice

  2013cites this paper
• Prime-Boost Strategies in Mucosal Immunization Affect Local IgA Production and the Type of Th Response

  2013cites this paper
• Investigation of spore coat display of Bacillus subtilis β-galactosidase for developing of whole cell biocatalyst

  2013cites this paper
• Microbial cell surface display; its medical and environ- mental applications

  2012cites this paper
• Relevant uses of surface proteins – display on self‐organized biological structures

  2012influential citation
• Bacillus subtilis

  2012cites this paper
• Cloning and expression of tetanus toxin C fragment (Fc) in prokaryotic vector for constructing recombinant protein based vaccine for tetanus

  2011cites this paper
• Innate and acquired immune responses induced by recombinant Lactobacillus casei displaying flagellin-fusion antigen on the cell-surface.

  2010cites this paper
• Genetic Immunization with CDR3-Based Fusion Vaccine Confers Protection and Long-Term Tumor-Free Survival in a Mouse Model of Lymphoma

  2010influential citation
• Surface display of recombinant protein on the cell surface of Bacillus subtilis by the CotB anchor protein

  2010cites this paper
• Expression of EspA in Lactococcus lactis NZ9000 and the detection of its immune effect in vivo and vitro

  2010cites this paper
• Variations of N-acetylation level of peptidoglycan do not influence persistence of Lactococcus lactis in the gastrointestinal tract.

  2010cites this paper
• Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4+ and CD8+ T cells in the genital and intestinal tracts.

  2010cites this paper
• Expression of recombinant T-cell epitopes in the cell and on the surface of Bacillus subtilis

  2009cites this paper
• Display of proteins on Bacillus subtilis endospores

  2009cites this paper
• Approaches and issues towards development of efficient mucosal vaccines against pneumonia

  2009cites this paper
• Synergistic BM-DC activation and immune induction by the oral vaccine vector Streptococcus gordonii and exogenous tumor necrosis factor.

  2009cites this paper
• Expression of a Functional Single-Chain Variable-Fragment Antibody against Complement Receptor 1 in Streptococcus gordonii

  2008cites this paper
• Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA.

  2008cites this paper
• Primary Activation of Antigen-Specific Naive CD4+ and CD8+ T Cells following Intranasal Vaccination with Recombinant Bacteria

  2008cites this paper
• Characterization of the local immune response to cyst antigens during the acute and elimination phases of primary murine giardiasis.

  2008cites this paper
• Candidate Live, Attenuated Salmonella enterica Serotype Typhimurium Vaccines with Reduced Fecal Shedding Are Immunogenic and Effective Oral Vaccines

  2007cites this paper
• Expression and purification of a trivalent pertussis toxin-diphtheria toxin-tetanus toxin fusion protein in Escherichia coli.

  2007cites this paper
• Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization.

  2006cites this paper
• Mucosal delivery of vaccine antigens and its advantages in pediatrics.

  2006cites this paper
• Stimulation of Human Monocytes with the Gram-Positive Vaccine Vector Streptococcus gordonii

  2006cites this paper
• Expression of the Giardia lamblia cyst wall protein 2 in Lactococcus lactis.

  2006cites this paper
• In Vivo Activation of Naive CD4+ T Cells in Nasal Mucosa-Associated Lymphoid Tissue following Intranasal Immunization with Recombinant Streptococcus gordonii

  2006cites this paper
• Mucosal delivery of vaccine antigens and its advantages in pediatrics.

  2006cites this paper
• Live bacterial vaccines – a review and identification of potential hazards

  2006cites this paper
• Toxicity, Mechanisms, Prophylaxis, and Therapy of Inhaled Biological Toxins

  2005cites this paper
• Clinical and Microbiological Responses of Volunteers to Combined Intranasal and Oral Inoculation with a Streptococcus gordonii Carrier Strain Intended for Future Use as a Group A Streptococcus Vaccine

  2005cites this paper
• Selection and characterization of a promoter for expression of single-copy recombinant genes in Gram-positive bacteria

  2005cites this paper
• Characterization and applications of Lactobacillus brevis S-layer proteins and evaluation of Lactococcus lactis as a porcine cytokine producer

  2005influential citation
• Commensal bacteria as a novel delivery system for subunit vaccines directed against agents of bioterrorism

  2005cites this paper
• Expression of a functional single-chain Fv antibody on the surface of Streptococcus gordonii.

  2004cites this paper
• Biotechnological applications for surface‐engineered bacteria

  2004cites this paper
• Progress toward development of an inhalation vaccine against botulinum toxin

  2004cites this paper
• Expression and Immunogenicity of a Recombinant Diphtheria Toxin Fragment A in Streptococcus gordonii

  2004cites this paper
• Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner.

  2004cites this paper
• Oral priming of mice by recombinant spores of Bacillus subtilis.

  2004cites this paper
• Mucosal and Cellular Immune Responses Elicited by Recombinant Lactococcus lactis Strains Expressing Tetanus Toxin Fragment C

  2004cites this paper
• In Vivo Phage Display to Identify M Cell-Targeting Ligands

  2004cites this paper
• Enhanced Mucosal Delivery of Antigen with Cell Wall Mutants of Lactic Acid Bacteria

  2004cites this paper
• Heterologous protein production and delivery systems for Lactococcus lactis.

  2003cites this paper
• Bacillus spores for vaccine delivery.

  2003cites this paper
• Bacterial spores as heat stable vaccine vehicles

  2003cites this paper
• Therapy and prophylaxis of inhaled biological toxins

  2003cites this paper
• Lactic Acid Bacteria as Mucosal Delivery Vehicles

  2003cites this paper
• Oral colonization and immune responses to Streptococcus gordonii: potential use as a vector to induce antibodies against respiratory pathogens

  2003cites this paper
• Rapid induction of autoantibodies against Nogo‐A and MOG in the absence of an encephalitogenic T cell response: implication for immunotherapeutic approaches in neurological diseases

  2003cites this paper
• Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens.

  2003cites this paper
• Engineering of staphylococcal surfaces for biotechnological applications.

  2002cites this paper
• The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1

  2002cites this paper
• Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations.

  2002cites this paper
• Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence.

  2002cites this paper
• Use of a rationally attenuated Bordetella bronchiseptica as a live mucosal vaccine and vector for heterologous antigens.

  2002cites this paper
• Biological consequences of antigen and cytokine co-expression by recombinant Streptococcus gordonii vaccine vectors.

  2002cites this paper
• Lactobacilli as live vaccine delivery vectors: progress and prospects.

  2002cites this paper
• Engineered Commensal Bacteria as Delivery Systems of Anti-infective Mucosal Protectants

  2002cites this paper
• Analysis of Factors Affecting Surface Expression and Immunogenicity of Recombinant Proteins Expressed by Gram-Positive Commensal Vectors

  2002cites this paper
• Biotechnological Approaches to Fight Pathogens at Mucosal Sites

  2001cites this paper
• Surface Display of Recombinant Proteins on Bacillus subtilis Spores

  2001influential citation